Scientists said Thursday that a new AIDS vaccine, the first ever declared to protect a significant minority of humans against the disease, would be studied to answer two fundamental questions: why it worked in some people but not in others, and why those infected despite vaccination got no benefit at all.

A United Nations program that has raised $1.2 billion over the past three years for the treatment of H.I.V./AIDS, malaria and tuberculosis through a small fee added to airline tickets sold in 15 countries is going global.

28 Medicine Shops In Delhi To Stock The Swine Flu Drug
Kounteya Sinha | TNN

New Delhi: The world

NATCO Pharma hopes to sell 10 million capsules of Natflu, the generic version of oseltamivir, the drug used to treat swine flu, by next month.

The Hyderabad-based company has tied up with healthcare chain Medplus for distribution and is in talks with other distributors to ramp up its supply chain across the country, said Natco Pharma director & chief financial officer P Bhaskara Narayana.

The Indian pharmaceutical market will treble to $20 billion from $7.1 billion (2007 figure) by 2015, with a compounded annual growth rate (CAGR) of 12.3 per cent.

THE increasing population of higher-income group in the country will open a potential $ 8-billion market for multinational companies selling costly drugs, including patented products, by 2015, a Ficci-Ernst & Young study said.

Sept. 18: Drug maker Natco Pharma on Friday said it has launched anti-swine flu drug Natflu.

"Natco Pharma has launched Natflu capsule, the cure for swine flu," the Hyderabad-based firm said in a statement.

The maximum retail price for the medicine is fixed at Rs 480 for a bottle of 10 capsules and is available in all licensed pharmacies, it further said.

While H1N1 vaccine has got regulatory approval abroad, Indian vaccine manufacturers are likely to start animal testing by the end of this month.

Dates were finalised after government gave Rs 10 crore each to three vaccine manufacturers

THE health ministry is in discussions with three multinational (MNC) drug makers

Joe C Mathew / New Delhi September 17, 2009, 0:31 IST

The central government